Biogen BIIB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.42B-4.0% | $1.34B-17.8% | $1.61B-0.4% | $1.53B+32.2% | $1.48B+26.7% | ||
| $801.1M+13.0% | $779.9M+15.8% | $763.7M+21.4% | $744.3M+30.2% | $708.9M+33.8% | ||
| $293.8M-1.9% | $290.8M-0.1% | $306.3M+13.0% | $303.7M+16.6% | $299.4M+14.5% | ||
| $2.59B+0.4% | $2.2B-23.3% | $2.45B+15.3% | $2.12B+18.7% | $2.58B+56.9% | ||
| $167.9M+15.9% | $153.8M+0.1% | $149.2M-16.9% | $138M-36.9% | $144.9M-43.5% | ||
| -$1.53B-96.5% | -$1.37B-71.6% | -$158M+89.0% | -$1.3B+34.6% | -$780.5M+75.7% | ||
| -$322.7M-17.4% | -$301.9M+56.3% | -$164.9M— | -$41.3M— | -$274.8M— | ||
| —— | —— | $2.14B— | —— | —— | ||
| $2.42B-0.6% | $2.05B-24.7% | $2.3B+15.2% | $1.98B+22.3% | $2.44B+69.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biogen generate?
- Biogen (BIIB) generated $2.6B in operating cash flow over the trailing twelve months.
- What is Biogen's free cash flow?
- After $167.9M of capital expenditures, Biogen's free cash flow was $2.4B over the trailing twelve months, down 0.6% year over year.
- Where does Biogen's cash flow data come from?
- Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
